Transcatheter Arterial Embolization for the treatment of upper gastrointestinal bleeding

Abstract

Background: Transcatheter arterial embolization can be used for patients with recurrent bleeding from the upper gastrointestinal tract after failed endoscopic treatment. Our aim to identify the clinical and technical factors that infl uenced the outcome of transcatheter embolization for therapy of upper gastrointestinal bleeding after failed surgery or after failed endoscopic treatment in high risk surgical patients. Methods: We performed a prospective study to analysis of the 15 patients who underwent Transcatheter arterial embolization for nonvariceal upper gastrointestinal bleeding at Alshifa hospital from January 2015 to March 2019. The following variables were recorded: demographic data, time from bleeding start to TAE, units of packed red cells before TAE and units of packed plasma before Transcatheter arterial embolization and we analysis 30 days rebleeding rates and mortality. Results: Patients treated with Transcatheter arterial embolization (median age: 62 years, range: 14–79 years).The technical success rate of the embolization procedure was 100%. Time from bleeding start to TAE was 2.1 (1-4) days , units of packed red cells before Transcatheter arterial embolization was 12.8 (4-22) packed and units of packed plasma was 3.2 (2-5) packed. Following 30 days after embolization, 2 (13%) patients had repeated bleeding and 3 (20.0%) patients died. Conclusion: In our experience, arterial embolization is a safe and effective treatment method for upper gastrointestinal bleeding and a possible alternative to surgery for high-risk patients. Research Article Transcatheter Arterial Embolization for the treatment of upper gastrointestinal bleeding Mohammed Habib1* and Majed Alshounat2 1Consultant, Interventional Cardiologist, Head of Cardiology Department, Alshifa Hospital, Gaza, Palestine 2Consultant, interventional Cardiologist. Alshifa Hospital, Gaza, Palestine *Address for Correspondence: Mohammed Habib, MD, PhD, Alshifa Hospital, Cardiology Department, Gaza, Palestine, Tel: 00972599514060; Email: cardiomohammad@yahoo.com Submitted: 22 May 2019 Approved: 06 June 2019 Published: 07 June 2019 Copyright: © 2019 Habib M, et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited How to cite this article: Habib M, Alshounat M. Transcatheter Arterial Embolization for the treatment of upper gastrointestinal bleeding. Ann Clin Gastroenterol Hepatol. 2019; 3: 006-011. https://dx.doi.org/10.29328/journal.acgh.1001008 Introduction Acute nonvariceal upper gastrointestinal (GI) bleeding remains a challenging presentation due to signi icant morbidity and mortality rates, and about half of all cases of upper GI bleeding are caused by gastric and duodenal ulcers. Although irstline endoscopy achieves bleeding control in most patients, if this does not work, the mortality rate can be 5% to 10% because of multiple comorbidi ties, advanced age, and high transfusion requirements. However, hospitalization and mortality due to severe upper gastrointestinal bleeding as a result of peptic ulcer are still high among the elderly [1-4]. Surgery is also associated with high mortality, and therefore, selective transcatheter arterial embolization (TAE) is considered a safer alternative due to the avoid ance of laparotomy, particularly in high-risk patients. In fact, in many institutions, TAE is now the irst-line intervention for massive arterial bleeding from the upper GI tract that is resistant to endoscopic therapy. Transcatheter Arterial Embolization for the treatment of upper gastrointestinal bleeding Published: June 07, 2019 007 Arterial embolization in the upper GI tract above the ligament of Treitz is generally considered to be very safe because of the rich collateral supply to the stomach and duodenum. We presents 15 cases of upper GIT bleeding treated successfully by arterial Embolization after failed endoscopy procedure. Methods From January 2015 to March 2019, 15 patients were referred to cardiac catheterization department with upper gastrointestinal bleeding. The typical candidate patient presents with the following: 1) massive bleeding (transfusion requirement of at least 3 U blood over 24 hours) or hemodynamic compromise (systolic blood pressure < 90 mm Hg and heart rate > 100 beats per minute or clinical shock), 2) endoscopy-refractory acute UGI bleeding, 3) recurrent bleeding after surgery. There are no absolute contraindications because angiography and embolization may be needed as lifesaving procedures. One patient was transferred from pediatric surgery and diagnosis was traumatic liver injury due to AV istula, 3 case transferred from general surgery and diagnosis was large liver hemangioma and liver cancer and 11 patients were transferred from internal medical department from Al Shifa hospital due to gastroduodenal ulcers, pancreatic cancer and liver pseudoaneurysm. The following variables were recorded: demographic data, CT or endoscopic diagnoses, comorbidities, lowest hemoglobin levels, total transfusion requirements, postprocedure complications, and mortality rates. Result The median age was, 62 years (age range, 14–82 years). Female was 3 patients (20%), The median time that passed from the clinical symptoms of bleeding to embolization was 4.2 days, 6 patients underwent multidetector computed tomography angiography (MDCTA) and 9 patient underwent endoscopy, For 1 patient, TAE was performed after failed endoscopic and surgical treatment due to duodenal ulcer, 6 patient underwent TAE because of high risk of surgery (2 liver cancer, 1 liver hemangioma, 1 pancreatic cancer, 1 right hepatic artery pseudoaneurysm after previous cholecystectomy, and 1 liver traumatic Arteriovenous istula), and 8 patients TAE was performed after failed endoscopic intervention. Baseline patient characteristics and the amount of packed red blood cells and freshly frozen plasma administered to the patients before TAE are presented in table 1. The most common of causes of bleeding are presented in table 2. The most common causes of bleeding were bleeding from gastroduodenal ulcers (9 cases, 60 %), followed by bleeding from liver cancer of hemangioma (3 cases, 20%) bleeding from pancreatic cancers (1 case, 6.7%), right hepatic artery pseudoaneurysm (1 case, 6.7%) and Liver traumatic AV istula (1 case, 6.7%) . The technical success rate of the embolization procedure, which was de ined as complete angiographic occlusion of the targeted vessels, was 100%. Out of the 15 cases, 12 (80%) were therapeutic embolizations, when the source of the bleeding was visualized during angiography, and 3 (20%) were prophylactic embolizations of the anatomical site. The sites of embolization are presented in table 3. Transcatheter Arterial Embolization for the treatment of upper gastrointestinal bleeding Published: June 07, 2019 008 No complications were reported after the procedure. Two (13%) patients had an episode of rebleeding within 30 days after the embolization procedure, one patients after TAE were treated surgically, and another patient was treated by re-embolization. Three (20.0%) of the patients died. (One patient liver cancer, one patient pancreatic cancer and last patient right hepatic artery pseudoaneurysm) Examples of the procedure are shown: Case 1 A 72-year-old female patient with upper GI bleeding, she had history of pancreas CA, she transferred to Al-Najah Hospital because Wipple operation. But the operation was failed. After failed operation massive PE and Melina was developed Endoscopy was done and suggested that bleeding from 2nd segment of duodenum. The Preoperative.: HgB: 6.8 g/dl despite 28 unit of blood and plasma transfusion. Urgent selective angiography was done and suggested cutoff of superior pancreatic duodenal artery and coil Embolization was done the patient was discharged after 2 days with good condition and HgB level was 10.5 g/dl. After 3 weeks repeat GIT bleeding was developed and HgB level was 8.3 g/dl, repeat Urgent selective angiography was done Embolization of gastro duodenal artery by Polyvinyl alcohol particle and coil Embolization was done the patient was discharged after 3 days with good condition and HgB level was 9.7 g/dl (Figure 1). Case 2 A 40-year-old female patient with thalasemia major and right hepatic mass presents with massive peritoneal bleeding from liver. The Pre-operative HgB:5.7 gram/dl, INR:2.84 despite 4 unit blood and 3 unit FFP transfusion. Left hepatic artery from celiac trunk and Right hepatic artery origin from proximal SMA. Urgent selective angiography was done and suggested Bleeding from RHA branches a srounding the mass in the right loupe of the liver. Absorbable gelatin sponge infusion and 3 Coil embolization was done (Figure 2). Table 1: Patients baseline characteristics. Parameter Variable Male, n (%) 12 (80) Female, n (%) 3 (20) Age: years (range) 62 (14-79) Time from bleeding start to TAE: days(range) 4.2 (2:7) Units of packed red cells before TAE: packed (range) 12.8 (4-22) Units of packed plasma before TAE: packed (range) 3.2 (2-5) Table 2: Causes of GIT bleeding. Causes No Percentage Gastroduodenal ulcers 9 60% Liver cancer 2 13% Liver hemangioma 1 6.7% Liver traumatic AV fi stula 1 6.7% Pseudoaneurysm 1 6.7% Pancreatic cancer 1 6.7% Total 15 100% Table 3: Site of Embolization. Embolized artery No. Percent Gastroduodenal artery 7 47% Hepatic artery 4 27% Left gastric artery 3 20% Gastroduodenal artery and right gastroepiploic artery 1 6.00% Total 15 100% Transcatheter Arterial Embolization for the treatment of upper gastrointestinal bleeding Published: June 07, 2019 009 Case 3 Female patient 79 years old with CHF and chronic AF and with history of Cholesystoectomy before 7 years, Presentation with recurrent Upper GIT Bleeding. The Pre-operative HgB:6.7 gram/dl, despite 6unit blood and 3 unit FFP transfusion Urgent selective angio